EcoDrugPlus

Cytochrome P450 3a30-Like

Ensembl ID : ENSSTUG00000045749
Gene Symbol: LOC115168548
2 Cross references
443 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSSTUG00000026712
Gene Symbol: CYP19A1
3 Cross references
244 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSSTUG00000020863
Gene Symbol: CYP26A1
3 Cross references
132 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSSTUG00000049941
Gene Symbol: CYP26A1
3 Cross references
132 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSSTUG00000039487
Gene Symbol: LOC115173752
3 Cross references
185 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSSTUG00000001630
Gene Symbol: LOC115201483
3 Cross references
207 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSSTUG00000008695
Gene Symbol: LOC115185682
3 Cross references
188 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSSTUG00000047985
Gene Symbol: LOC115175571
3 Cross references
184 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSSTUG00000044716
Gene Symbol: LOC115174058
3 Cross references
184 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1b

Ensembl ID : ENSSTUG00000048171
Gene Symbol: DGAT1B
1 Cross references
188 Possible Orthologues:

Dihydroorotate Dehydrogenase

Ensembl ID : ENSSTUG00000007863
Gene Symbol: DHODH
1 Cross references
167 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSSTUG00000045359
Gene Symbol: DHODH
3 Cross references
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).